Sandra Röhm studied Biomedicinal Chemistry at the Johannes Gutenberg University and at the Max Planck Institute for Polymer Research in Mainz. For her scientific achievements in the field of Chemistry, she was awarded with the Adolf Todt prize from the University of Mainz. In 2015 she joined Professor Stefan Knapp‘s group and the Structural Genomics Consortium in Frankfurt. During her Ph.D. studies, she successfully developed chemical probes targeting the mitogen activated protein kinase p38 and the discoidin domain receptor kinase. In 2020 she continued as a postdoc and worked on kinase inhibitors for Parkinson's disease. As leader of WP2 in the EUbOPEN Consortium, she is coordinating the effort to generate a chemogenomic compound library. Together with her team, her current research interests focus on the design of covalent and allosteric inhibitors with structural novelties.